OPNT Opiant Pharmaceuticals Inc.

Opiant Pharmaceuticals Inc is a specialty pharmaceutical company. The Company develops opioid pharmacological treatments for substance use, addictive and eating disorders.

As of 04/13/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  4,291,632
Average volume:  23,345
Market cap:   $45,405,467
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    683750103
ISIN:        US6837501039
Sedol:      BYXZVL7
Valuation   (See tab for details)
PE ratio:   -24.25
PB ratio:   1.26
PS ratio:   1.53
Return on equity:   -5.24%
Net income %:   -6.28%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy